Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mytocel MSK
- Development stage
- Phase 1
- Lead developer
- Taichung Veterans General Hospital
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
Mytocel MSK is an autologous micrograft tissue therapy designed for the treatment of musculoskeletal conditions, specifically knee osteoarthritis (grades 1-3) and tendinopathies. The procedure involves harvesting a small tissue sample, such as ear cartilage, and processing it using Rigenera® technology to create a micrograft solution. This suspension is rich in cartilage precursor cells and mesenchymal stem cell markers, including CD44, CD90, and CD117. When injected intra-articularly, the therapy promotes regenerative repair of the cartilage, reduces inflammation, and alleviates pain and stiffness. It is currently being evaluated in clinical trials at Taichung Veterans General Hospital as a potentially more effective and longer-lasting alternative to platelet-rich plasma (PRP) injections.
- Brand names
- Mytocel MSK
- Other names
- Autologous Micrograft TissueAMT
Beyond the preview
Go deeper on Mytocel MSK.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mytocel MSK.